122 related articles for article (PubMed ID: 4421563)
1. Sensitisation of lymphocytes in vitro against human melanoma-associated antigens.
Golub SH; Morton DL
Nature; 1974 Sep; 251(5471):161-3. PubMed ID: 4421563
[No Abstract] [Full Text] [Related]
2. Characterisation of human malignant melanoma cell lines. VI. Inhibition of 3H-thymidine uptake by normal stimulated lymphocytes.
Lui VK; Dent PB; Liao SK
Oncology; 1977; 34(6):251-4. PubMed ID: 593653
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of lymphocytes in vitro to reactions against cultured Burkitt's lymphoma cells.
Golub SH; Hewetson JF; Svedmyr AJ; Klein G; Singh S
Natl Cancer Inst Monogr; 1973 Jun; 37():25-32. PubMed ID: 4713782
[No Abstract] [Full Text] [Related]
4. Harding-Passey melanoma in the BALB-C mouse as a model for studying the interactions between host macrophages and tumor cells.
Lejeune FJ
Yale J Biol Med; 1973 Dec; 46(5):368-83. PubMed ID: 4205114
[No Abstract] [Full Text] [Related]
5. The use of viable frozen lymphocytes for studies in human tumor immunology.
Golub SH; Sulit HL; Morton DL
Transplantation; 1975 Mar; 19(3):195-202. PubMed ID: 124484
[TBL] [Abstract][Full Text] [Related]
6. Generation of cytotoxic lymphocytes against human tumor cells in vitro by various soluble microbial extracts.
Sharma B; Brunda MJ; Minden P
J Natl Cancer Inst; 1979 Aug; 63(2):341-6. PubMed ID: 222929
[No Abstract] [Full Text] [Related]
7. Lymphocyte stimulation in vitro: generation of cytotoxic effector lymphocytes using subcellular fractions of a lymphoid cell line.
Corley RB; Dawson JR; Amos DB
Cell Immunol; 1975 Mar; 16(1):92-105. PubMed ID: 123177
[No Abstract] [Full Text] [Related]
8. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
[TBL] [Abstract][Full Text] [Related]
9. Evidence for immune reactivity against neoplasms.
McKhann CF; Jagarlamoody SM
Transplant Rev; 1971; 7():55-77. PubMed ID: 4112673
[No Abstract] [Full Text] [Related]
10. Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium-99m labeled target cells.
Gillespie GY; Barth RF
Cancer; 1978 Jun; 41(6):2174-82. PubMed ID: 350374
[No Abstract] [Full Text] [Related]
11. In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. II. Sensitization against melanoma-associated antigens.
Golub SH
Cell Immunol; 1977 Feb; 28(2):379-89. PubMed ID: 849604
[No Abstract] [Full Text] [Related]
12. In vitro lymphocyte reactivity to soluble tumor extracts in Sinclair melanoma swine.
Aultman MD; Hook RR
Int J Cancer; 1979 Nov; 24(5):673-8. PubMed ID: 528082
[No Abstract] [Full Text] [Related]
13. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
[No Abstract] [Full Text] [Related]
14. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
Jehn UW; Nathanson L; Schwartz RS; Skinner M
N Engl J Med; 1970 Aug; 283(7):329-33. PubMed ID: 4193645
[No Abstract] [Full Text] [Related]
15. [Cytotoxic immunity indices of melanoma B16 growth in mice].
Korosteleva TA; Veresova OV
Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
[TBL] [Abstract][Full Text] [Related]
16. Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response.
Chess L; Bock GN; Ungaro PC; Buchholz DH; Mardiney MR
J Natl Cancer Inst; 1973 Jul; 51(1):57-65. PubMed ID: 4720886
[No Abstract] [Full Text] [Related]
17. Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients.
Vanwijck R; Bouillenne C; Malek-Mansour S
Eur J Cancer (1965); 1975 Apr; 11(4):267-76. PubMed ID: 1079770
[No Abstract] [Full Text] [Related]
18. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
[TBL] [Abstract][Full Text] [Related]
19. Human malignant melanoma cells: morphological and immunological variations.
Hakim AA
Neoplasma; 1977; 24(1):81-99. PubMed ID: 840339
[TBL] [Abstract][Full Text] [Related]
20. Recognition and destruction of target cells by tumoricidal macrophages.
Fidler IJ
Isr J Med Sci; 1978 Jan; 14(1):177-91. PubMed ID: 204610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
